Skip to search boxSkip to navigationSkip to main content

Mediating Effects of Frailty Indicators on the Risk of Sepsis After Cancer

  • Justin Xavier Moore(corresponding author)
    ,
  • Tomi Akinyemiju
    ,
  • Alfred Bartolucci
    ,
  • Henry E. Wang
    ,
  • John Waterbor
    ,
  • Russell Griffin
*Corresponding author for this work
  • University of Alabama at Birmingham
    ,
  • Washington University St. Louis
    ,
  • University of Kentucky
    ,
  • University of Texas Health Science Center at Houston
Scholary Output:
Contribution to journal
Article
Peer-review

Open access

Sustainable Development Goals

  • SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well

Abstract

Background: Cancer survivors are at increased risk of sepsis, possibly attributed to weakened physiologic conditions. The aims of this study were to examine the mediation effect of indicators of frailty on the association between cancer survivorship and sepsis incidence and whether these differences varied by race. Methods: We performed a prospective analysis using data from the REasons for Geographic and Racial Differences in Stroke cohort from years 2003 to 2012. We categorized frailty as the presence of ≥2 frailty components (weakness, exhaustion, and low physical activity). We categorized participants as “cancer survivors” or “no cancer history” derived from self-reported responses of being diagnosed with any cancer. We examined the mediation effect of frailty on the association between cancer survivorship and sepsis incidence using Cox regression. We repeated analysis stratified by race. Results: Among 28 062 eligible participants, 2773 (9.88%) were cancer survivors and 25 289 (90.03%) were no cancer history participants. Among a total 1315 sepsis cases, cancer survivors were more likely to develop sepsis (12.66% vs 3.81%, P <.01) when compared to participants with no cancer history (hazard ratios: 2.62, 95% confidence interval: 2.31-2.98, P <.01). The mediation effects of frailty on the log-hazard scale were very small: weakness (0.57%), exhaustion (0.31%), low physical activity (0.20%), frailty (0.75%), and total number of frailty indicators (0.69%). Similar results were observed when stratified by race. Conclusion: Cancer survivors had more than a 2-fold increased risk of sepsis, and indicators of frailty contributed to less than 1% of this disparity.

Publication Information

Output type

Scholary Output:
Contribution to journal
Article
Peer-review

Original language

English (US)

Pages from-to (Number of pages)

Pages 708-719 (12 pages)

Journal (Volume, Issue Number)

Journal of Intensive Care Medicine (Volume 35, Issue 7)

Publication milestones

  • Accepted/In press - 01/01/2018
  • Published - 07/01/2020

Publication status

Published - 07/01/2020

ISSN

0885-0666

Publication IDs

  • Scopus: 85048035214
  • PubMed: 29862879

Publication metrics

Metrics

Scopus
citations
SciVal
Author count
6
SciVal
citations
1
SciVal
Paper percentile
68
Fractional count
1
Fractional count
0.17
Fractional count
5
Fractional count
0.83
Fractional count
1
Fractional count
1

PlumX, opens in new tab

Captures
60
Citation count
7

Funding Details

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Dr Justin Xavier Moore received grant support from (grant R25 CA47888) the Cancer Prevention and Control Training Program, funded by the National Cancer Institute, National Institutes of Health. Dr Justin Xavier Moore was additionally supported by grant T32190194 from the National Cancer Institute (Colditz) and by the foundation for Barnes Jewish Hospital and by Siteman Cancer Center. This work was supported by award (grant number R01-NR012726) from the National Institute for Nursing Research, from the National Center for Research Resources (grant number UL1-RR025777), as well as by grants from the Center for Clinical and Translational Science and the Lister Hill Center for Health Policy of the University of Alabama at Birmingham. The parent REGARDS study was supported by cooperative agreement (grant number U01-NS041588) from the National Institute of Neurological Disorders and Stroke, National Institutes of Health, and Department of Health and Human Service. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies. Representatives of the funding agencies have been involved in the review of the manuscript but not directly involved in the collection, management, analysis, or interpretation of the data.
FundersFunding numbers
NIH
T32190194
HHS
-
NCI
-
NINR
-
NINDS
-
NCRR
UL1RR025777
Foundation for Barnes-Jewish Hospital
-
CCTS, UIC
-
UA
U01-NS041588
Alvin J. Siteman Cancer Center
R01-NR012726